Gallbladder Neoplasms Clinical Trial
Official title:
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms: Phase I and Phase II Clinical Trial
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Gallbladder Neoplasms.
By enrolling patients with unresectable Gallbladder Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Gallbladder Neoplasms. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
| Completed |
NCT01053390 -
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
|
Phase 3 | |
| Completed |
NCT03510923 -
Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
|
||
| Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06276153 -
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
|
||
| Completed |
NCT06178848 -
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
|
N/A | |
| Withdrawn |
NCT02174575 -
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
|
Phase 4 | |
| Recruiting |
NCT04140552 -
Chinese Research Group of Gallbladder Cancer
|
||
| Completed |
NCT01242605 -
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
|
Phase 1 |